Premium
Feasibility trial of the dialectical behavior therapy skills training group as add‐on treatment for adults with attention‐deficit/hyperactivity disorder
Author(s) -
Moritz Guilherme R.,
Pizutti Leandro T.,
Cancian Ana C. M.,
Dillenburg Mariana S.,
Souza Lucas A. S.,
Lewgoy Laura B.,
Basso Patrícia,
Andreola Michel M. P.,
Bau Claiton H. D.,
Victor Marcelo M.,
Teche Stefania P.,
Grevet Eugênio H.,
Philipsen Alexandra,
Rohde Luis A. P.
Publication year - 2021
Publication title -
journal of clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.124
H-Index - 119
eISSN - 1097-4679
pISSN - 0021-9762
DOI - 10.1002/jclp.23049
Subject(s) - attention deficit hyperactivity disorder , psychology , attendance , dialectical behavior therapy , randomized controlled trial , clinical trial , clinical psychology , psychiatry , parent training , intervention (counseling) , medicine , borderline personality disorder , economics , economic growth
Objective Our aim was to explore the feasibility, and efficacy of a Dialectical Behavior Therapy Skill Training Group (DBT‐ST) as an add‐on treatment for adult attention‐deficit/hyperactivity disorder (ADHD) in Latin America. Method Adults with ADHD ( n = 31) with stable medication treatment for ADHD and residual symptoms (ASRS > 20) were randomly assigned to DBT‐ST ( n = 16) or treatment as usual (TaU; n = 15) for 12 weeks. Feasibility was accessed by attendance and completion rates at 12 weeks. Efficacy outcomes were measured with the ASRS, and performed at 0, 6, 12, and 16 weeks. Results The DBT‐ST protocol had 81.25% completion rate, with a mean attendance of 87.25% of the sessions. No significant interactions between group and time were detected for outcome measures. Discussion The DBT‐ST was feasible as add‐on treatment for adult patients with ADHD in Latin America. Replicating previous findings, DBT‐ST has shown no significantly higher improvement in ADHD symptoms in comparison with TaU. Registered at the Clinical Trials database (NCT03326427).